SOD3 and pancreatic neoplasm: In pancreatic cancer cells, P-AscH− treatment (10 pmole/cell, 1 mM for 1 h) increased EcSOD expression 48 h later after treatment, with no increases in normal pancreatic epithelial cells (Figure 5).